Novartis | NOVN - Gastos De Venta Y Administración

Precio De Mercado
116.68
Cambio Diario
-0.12 -0.10%
Mensual
-0.63%
Anual
27.56%
Q2 Expectativa
111.13




Gastos De Venta Y Administración Cambio Fecha
AbbVie USD 3.58B 316M 2026-03
Alcon AG USD 882M 19M 2026-03
Amgen USD 1.58B 354M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Autolus Therapeutics Ltd USD 39.95M 4.16M 2026-03
Bayer EUR 3.7B 356M 2026-03
Biogen USD 554.3M 128.2M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 749M 36M 2026-03
Genmab DKK 208M 60M 2025-12
Gilead Sciences USD 1.45B 326M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
GRIFOLS EUR 281M 5.7M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
J&J USD 6.03B 719M 2026-03
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Merck EUR 1.6B 136M 2025-12
Merck USD 2.67B 180M 2026-03
Novartis USD 3.14B 296M 2026-03
Novartis USD 3.44B 132M 2025-12
Novo Nordisk DKK 13.22B 4.22B 2026-03
Orion EUR 91.9M 18.8M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Philips EUR 1.18B 121M 2026-03
Recordati EUR 187.24M 15.86M 2025-12
Regeneron Pharmaceuticals USD 647.7M 127.3M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
UCB EUR 1.47B 193M 2025-12